U.S. National Institutes of Health

Developmental Therapeutics Project Management Office

Compounds entering the joint early therapeutics development program will be managed by project teams with members from both DCTD and CCR. A new Developmental Therapeutics Project Management Office will employ a business-focused approach for tracking the advancement of agents from discovery through completion.

The office will track compounds in exploratory IND studies as well as those targeted therapies being supported by collaborations between DTP and the DCTD Cancer Therapy Evaluation Program (CTEP).